Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Determining what age to move from stocks to bonds is vital for long-term financial health. Explore guidelines to help you plan your investment strategy.
23,118 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
Oil markets may stay tight for years. This guide explains why and highlights two energy stocks that fit a higher-for-...
Rising costs in AI model development are reshaping the investing landscape. This guide explains the drivers, the semi...
Applied Optoelectronics led a broader retreat in photonics stocks on July 2, 2026, with Coherent and Lumentum sliding...
A small-cap space stock can swing wildly, but patient, disciplined investors can map out potential outcomes. This gui...
Palantir and CoreWeave are at the center of the AI investment wave. This guide breaks down which is better for your p...
A contrarian take on the tech sell-off. Learn why durable AI and cloud trends could spark a rebound and how to positi...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
When expanding beyond U.S. borders, two giants compete for your international exposure: Vanguard VEA and iShares IEFA...
The Nasdaq Composite slipped on Tuesday as investors rotated away from AI-driven tech names, with chipmakers leading ...
Markets are betting that rates will edge lower this year, nudging investors toward income-focused and rate-sensitive ...